Rallybio Corporation RLYB
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | 212.00K | 222.00K | 212.00K | 212.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 212.00K | 222.00K | 212.00K | 212.00K |
| Cost of Revenue | 758.00K | 1.27M | 3.66M | 4.14M | 6.07M |
| Gross Profit | -758.00K | -1.06M | -3.43M | -3.93M | -5.86M |
| SG&A Expenses | 4.90M | 5.37M | 2.98M | 2.99M | 4.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.65M | 6.64M | 6.63M | 7.14M | 10.27M |
| Operating Income | -5.65M | -6.43M | -6.41M | -6.93M | -10.06M |
| Income Before Tax | 44.99M | -8.28M | -5.85M | 16.02M | -9.70M |
| Income Tax Expenses | 1.32M | -- | -- | -- | -- |
| Earnings from Continuing Operations | 43.67M | -8.28M | -5.85M | 16.02M | -9.70M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 43.67M | -8.28M | -5.85M | 16.02M | -9.70M |
| EBIT | -5.65M | -6.43M | -6.41M | -6.93M | -10.06M |
| EBITDA | -5.65M | -6.43M | -6.41M | -6.89M | -10.03M |
| EPS Basic | 7.66 | -1.46 | -1.03 | 2.84 | -1.73 |
| Normalized Basic EPS | 4.93 | -0.66 | -0.64 | -0.72 | -1.08 |
| EPS Diluted | 7.53 | -1.46 | -1.03 | 2.84 | -1.73 |
| Normalized Diluted EPS | 4.85 | -0.66 | -0.64 | -0.72 | -1.08 |
| Average Basic Shares Outstanding | 5.70M | 5.69M | 5.68M | 5.63M | 5.61M |
| Average Diluted Shares Outstanding | 5.80M | 5.69M | 5.68M | 5.63M | 5.61M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |